The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Effect of Screening Mammography on Breast-Cancer Mortality in Norway
Open accessAbstract
BACKGROUND: A challenge in quantifying the effect of screening mammography on breast-cancer mortality is to provide valid comparison groups. The use of historical control subjects does not take into account chronologic trends associated with advances in breast-cancer awareness and treatment. METHODS: The Norwegian breast-cancer screening program was started in 1996 and expanded geographically during the subsequent 9 years. Women between the ages of 50 and 69 years were offered screening mammography every 2 years. We compared the incidence-based rates of death from breast cancer in four groups: two groups of women who from 1996 through 2005 were living in counties with screening (screening group) or without screening (nonscreening group); and two historical-comparison groups that from 1986 through 1995 mirrored the current groups. RESULTS: We analyzed data from 40,075 women with breast cancer. The rate of death was reduced by 7.2 deaths per 100,000 person-years in the screening group as compared with the historical screening group (rate ratio, 0.72; 95% confidence interval [CI], 0.63 to 0.81) and by 4.8 deaths per 100,000 person-years in the nonscreening group as compared with the historical nonscreening group (rate ratio, 0.82; 95% CI, 0.71 to 0.93; P<0.001 for both comparisons), for a relative reduction in mortality of 10% in the screening group (P=0.13). Thus, the difference in the reduction in mortality between the current and historical groups that could be attributed to screening alone was 2.4 deaths per 100,000 person-years, or a third of the total reduction of 7.2 deaths. CONCLUSIONS: The availability of screening mammography was associated with a reduction in the rate of death from breast cancer, but the screening itself accounted for only about a third of the total reduction. (Funded by the Cancer Registry of Norway and the Research Council of Norway.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
Self-citationScreening for breast cancer with mammography
Gøtzsche, P. C., & Jørgensen, K. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub5 · Cited by 1,869
European guidelines for quality assurance in breast cancer screening and diagnosis
Amendoeira, I., Perry, N., Broeders, M. J. M., de Wolf, C., Törnberg, S., Holland, R. D., & von Karsa, L. (2013) · Zurich Open Repository and Archive (University of Zurich) · doi:10.2772/13196 · Cited by 1,556
Feinstein, A. R., Sosin, D. M., & Wells, C. K. (1985) · New England Journal of Medicine · doi:10.1056/nejm198506203122504 · Cited by 1,544
Long-term effects of mammography screening: updated overview of the Swedish randomised trials
Nyström, L., Andersson, I., Bjurstam, N., Frisell, J., Nordenskjöld, B., & Rutqvist, L. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08020-0 · Cited by 1,183
Breast cancer screening with mammography: overview of Swedish randomised trials
Nyström, L., Wall, S., Rutqvist, L. E., Lindgren, A., Lindqvist, M., Rydén, S., Andersson, J., Bjurstam, N., Fagerberg, G., Frisell, J., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)91067-v · Cited by 968
Miller, A. B., Baines, C. J., To, T. M., & Wall, C. (1992) · Europe PMC (PubMed Central) · Cited by 864
Larsen, I. K., Småstuen, M., Johannesen, T. B., Langmark, F., Parkin, D. M., Bray, F., & Møller, B. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.037 · Cited by 848
Self-citationTabar, L., Yen, M.-F., Vitak, B., Chen, H.-H. T., Smith, R. A., & Duffy, S. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13143-1 · Cited by 742
Effect of Screening and Adjuvant Therapy on Mortality From Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000201966.23445.91 · Cited by 386
Self-citation
Cited by
Screening for breast cancer with mammography
Gøtzsche, P. C., & Jørgensen, K. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub5 · Cited by 1,869
Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
Bleyer, A., & Welch, H. G. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206809 · Cited by 1,367
Screening, T. I. U. P. O. B. C., Marmot, M. G., Altman, D. G., Cameron, D. A., Dewar, J. A., Thompson, S. G., & Wilcox, M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.177 · Cited by 1,069
Breast-Cancer Screening — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Benbrahim-Tallaa, L., Bouvard, V., Bianchini, F., & Straif, K. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1504363 · Cited by 962
International Variation in Female Breast Cancer Incidence and Mortality Rates
DeSantis, C. E., Bray, F., Ferlay, J., Lortet-Tieulent, J., Anderson, B. O., & Jemal, A. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0535 · Cited by 804
Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness
Welch, H. G., Prorok, P. C., O’Malley, A. J., & Kramer, B. S. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600249 · Cited by 699
Benefits and Harms of Breast Cancer Screening: A Systematic Review
Myers, E. R., Moorman, P., Gierisch, J. M., Havrilesky, L. J., Grimm, L. J., Ghate, S., Davidson, B., Mongtomery, R. C., Crowley, M. J., McCrory, D. C., et al. (2015) · JAMA · doi:10.1001/jama.2015.13183 · Cited by 637
Nelson, H. D., Fu, R., Cantor, A., Pappas, M., Daeges, M., & Humphrey, L. (2016) · Annals of Internal Medicine · doi:10.7326/m15-0969 · Cited by 611
Broeders, M., Moss, S., Nyström, L., Njor, S., Jonsson, H., Paap, E., Massat, N., Duffy, S., Lynge, E., & Paci, E. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012078 · Cited by 489
Overdiagnosis and Overtreatment in Cancer: An Opportunity for Improvement
Esserman, L. J., Thompson, I. M., & Reid, B. (2013) · JAMA · doi:10.1001/jama.2013.108415 · Cited by 467
Challenges to the early diagnosis and treatment of breast cancer in developing countries
Unger-Saldaña, K. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i3.465 · Cited by 439
Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women
Duffy, S. W., Tabár, L., Yen, A. M., Dean, P. B., Smith, R. A., Jonsson, H., Törnberg, S., Chen, S. L., Chiu, S. Y., Fann, J. C., et al. (2020) · Cancer · doi:10.1002/cncr.32859 · Cited by 412
Overdiagnosis in Mammographic Screening for Breast Cancer in Europe: A Literature Review
Puliti, D., Duffy, S. W., Miccinesi, G., De Koning, H., Lynge, E., Zappa, M., & Paci, E. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012082 · Cited by 407
From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer
Nevala-Plagemann, C., Hidalgo, M., & Garrido-Laguna, I. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0281-6 · Cited by 393
Effects of Age on the Detection and Management of Breast Cancer
McGuire, A., Brown, J., Malone, C., McLaughlin, R., & Kerin, M. (2015) · Cancers · doi:10.3390/cancers7020815 · Cited by 374
Long-Term Colorectal-Cancer Mortality after Adenoma Removal
Løberg, M., Kalager, M., Holme, Ø., Hoff, G., Adami, H.-O., & Bretthauer, M. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315870 · Cited by 345
Self-citationAutier, P., Boniol, M., Gavin, A., & Vatten, L. J. (2011) · BMJ · doi:10.1136/bmj.d4411 · Cited by 300
Pan-Canadian Study of Mammography Screening and Mortality from Breast Cancer
Coldman, A., Phillips, N., Wilson, C., Decker, K., Chiarelli, A. M., Brisson, J., Zhang, B., Payne, J., Doyle, G., & Ahmad, R. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju261 · Cited by 295
The WISDOM Study: breaking the deadlock in the breast cancer screening debate
Esserman, L. J., the WISDOM Study and Athena Investigators, Anton-Culver, H., Borowsky, A., Brain, S., Cink, T., Crawford, B., Eklund, M., Esserman, L., Fenton, J., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0035-5 · Cited by 272
Trends and predictions to 2020 in breast cancer mortality in Europe
Carioli, G., Malvezzi, M., Rodriguez, T., Bertuccio, P., Negri, E., & La Vecchia, C. (2017) · The Breast · doi:10.1016/j.breast.2017.06.003 · Cited by 264
Screening Mammography — A Long Run for a Short Slide?
Welch, H. G. (2010) · New England Journal of Medicine · doi:10.1056/nejme1008369 · Cited by 113
Resource-stratified implementation of a community-based breast cancer management programme in Peru
Duggan, C., Dvaladze, A. L., Tsu, V., Jeronimo, J., Constant, T. K. H., Romanoff, A., Scheel, J. R., Patel, S., Gralow, J. R., & Anderson, B. O. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30592-2 · Cited by 34
Lee, J. T., Huang, Z., Basu, S., & Millett, C. (2015) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2014-204355 · Cited by 27
Preventive service use among people with and without serious mental illnesses.
Yarborough, B. J. H., Perrin, N. A., Stumbo, S. P., Muench, J., & Green, C. A. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.08.020 · Cited by 13
Metadata
- Authors
- Kalager, M., Zelen, M., Langmark, F., & Adami, H.-O.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-09-23
- Volume
- 363
- Issue
- 13
- Pages
- 1203-1210
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2154747307
- Cited by
- 526
- References
- 20
- FWCI
- 30.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.